` SCS (Stem Cells Spin SA) vs WIG20 Comparison - Alpha Spread

S
SCS
vs
W
WIG20

Over the past 12 months, SCS has significantly outperformed WIG20, delivering a return of +78% compared to the WIG20's +29% growth.

Stocks Performance
SCS vs WIG20

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
SCS vs WIG20

Loading
SCS
WIG20
Difference
www.alphaspread.com

Performance By Year
SCS vs WIG20

Loading
SCS
WIG20
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Stem Cells Spin SA vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Stem Cells Spin SA
Glance View

Market Cap
15m PLN
Industry
Biotechnology

Stem Cells Spin SA engages in the development, manufacturing, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care markets. The company is headquartered in Wroclaw, Woj. Dolnoslaskie. The company went IPO on 2011-10-25. The company is primarily engaged in biotechnology research. The firm is focused on development, production, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care markets.

SCS Intrinsic Value
0.119 PLN
Overvaluation 67%
Intrinsic Value
Price
S
Back to Top